APA (7th ed.) Citation

HL, P., IR, Y., SH, B., SY, P., JK, P., SW, S., & SW, M. (2019). Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients? Journal of cancer research and clinical oncology, 145(4), 1021. https://doi.org/10.1007/s00432-019-02858-7

Chicago Style (17th ed.) Citation

HL, Park, Yoo IR, Boo SH, Park SY, Park JK, Sung SW, and Moon SW. "Does FDG PET/CT Have a Role in Determining Adjuvant Chemotherapy in Surgical Margin-negative Stage IA Non-small Cell Lung Cancer Patients?" Journal of Cancer Research and Clinical Oncology 145, no. 4 (2019): 1021. https://doi.org/10.1007/s00432-019-02858-7.

MLA (9th ed.) Citation

HL, Park, et al. "Does FDG PET/CT Have a Role in Determining Adjuvant Chemotherapy in Surgical Margin-negative Stage IA Non-small Cell Lung Cancer Patients?" Journal of Cancer Research and Clinical Oncology, vol. 145, no. 4, 2019, p. 1021, https://doi.org/10.1007/s00432-019-02858-7.